Reconbinant monoclonal antibody for Ulcerative Colitis(kexing)

N/A

Report date: 2025/09/29 16:58:49

Base Information

Drug NameReconbinant monoclonal antibody for Ulcerative Colitis(kexing)
Drug Alias NameGB20GB-20
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor superfamily member 15 modulators
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A